LDS/Medical Tests/Multiple Sulfatase Deficiency, Gene Mutation Analysis

Multiple Sulfatase Deficiency, Gene Mutation Analysis

Multiple sulfatase deficiency (MSD) is a rare autosomal recessive inherited metabolic defect due to deficiency of all lysosomal and microsomal sulfatase enzymes due to a defect in their post-translational modification. All sulfatases require activation by formylglycine generating enzyme (FGE) which is encoded by the sulfatase-modifying factor 1 (SUMF1) gene at 3p26.1. Over 50 pathogenic mutations in SUMF1 have been reported that cause MSD. In MSD, sulfatides, sphingolipids, sulfated glycosaminoglycans, and steroid sulfates accumulate in the tissue.

Each sibling of an affected person has a 25% chance of being affected, a 50% probability of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier at conception. There are three general types of MSD: neonatal, infantile, and juvenile. The most severe one is neonatal MSD which causes intrauterine growth restriction and respiratory distress in newborns. Coarse facial features, thick eyebrows, hypoplastic nasal bone, bulbous nasal tip, posteriorly rotated ears, high arched palate, micrognathia, retrognathia, flaring thorax, inverted nipples, and large thumbs are all examples of dysmorphic characteristics seen in neonatal MSD. Infantile MSD is characterized by progressive neurodegeneration and loss of sensory and motor functions. The juvenile type is the rarest and least severe form of multiple sulfatase deficiency and affected people initially have a normal early cognitive development but thereafter undergo psychomotor regression. The most commonly identified SUMF1 mutations causing MSD are c.463T>C, c.739G>C, c.788G>T, c.836C>T, c.1033C>T, and c.1045C>T. The identification of the mutants diagnoses multiple sulfatase deficiency. If the pathogenic variations in the family are known, detection of mutations can be useful in carrier testing for at-risk family members and prenatal testing for high-risk pregnancies.

  • Diagnosis of multiple sulfatase deficiency
  • Carrier testing in adults with a family history of multiple sulfatase deficiency
  • Screening neonates with a familial history of multiple sulfatase deficiency
A positive result indicates mutations or pathogenic variant in the SUMF1 gene. Pathogenic variants include c.463T>C, c.739G>C, c.788G>T, c.836C>T, c.1033C>T, and/ or c.1045C>T. A negative result indicates absence of one of the common mutations or pathogenic variants in the SUMF1 gene, however, it does not exclude the diagnosis and if clinically warranted additional genetic testing is recommended. 

Negative for mutations. (No mutations on the targeted genes were detected)

Next-generation sequencing (NGS), Sanger sequencing.

Whole blood in EDTA (Lavender top tube).

Stability

  • Ambient: 3-5 days
  • Refrigerated: 7-14 days
  • Frozen: unacceptable
Metabolic Storage Disease Gene Mutation Panel by NGS.
1-2 weeks.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login